Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, as amended from time to time, the "Trading Window" for dealing/trading in the shares of the Company shall remain closed ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GKB Ophthalmics Ltd has informed BSE that the trading window for dealing in its shares will remain closed starting January 01, 2026, until 48 hours after the declaration of financial results for the quarter ended December 31, 2025. This restriction applies to all Promoters, Directors, Designated Persons of the company, and their immediate relatives. The company has stated that the date of the Board Meeting to consider these results will be communicated separately. The closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
This is a routine regulatory compliance announcement ahead of quarterly results and does not directly affect shareholders. Investors should watch for the upcoming Q3 results announcement, which is likely to be the next material catalyst for the stock.